| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥22.84B | +33.7% |
| Gross profit | ¥18.60B | — |
| Operating income | ¥10.66B | — |
| Net income | ¥8.32B | +79.1% |
| Gross margin | 81.4% | Net margin 36.4% |
| Revenue Q/Q | +130.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥4.24B | 18.6% |
| R&D | ¥0.12B | 0.5% |
| SG&A | ¥4.66B | 20.4% |
| Tax & other | ¥2.34B | 10.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
双汇发展 ・ 紫光股份 ・ 华东医药 ・ 山金国际 ・ 浪潮信息 ・ 华工科技 ・ 华润三九 ・ 中国铀业 ・ 国货航 ・ 招商公路 ・ 招商蛇口 ・ 新和成
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies